Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00677326

Terminated

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer

Breast Cancer
NCT01022333

Unknown

The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

Breast Cancer
NCT00750464

Completed

Collection of Raw Data of Thermal Imaging for the Purpose of Developing a Device for Early Detection of Breast Cancer

Breast Cancer
NCT00484614

Unknown

Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer

Breast Cancer
NCT00954135

Unknown

Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients

Breast Cancer
NCT00123929

Completed

Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer

Breast Cancer
NCT00156039

Completed

Randomized Trial of Follow-up Strategies in Breast Cancer

Breast Cancer
NCT00938171

Unknown

Comparing Local Anesthesia With General Anesthesia for Breast Cancer Surgery

Breast Cancer
NCT00801411

Unknown

Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery

Breast Cancer
NCT00306631

Completed

A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1

Breast Cancer
NCT00063570

Completed

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

Breast Cancer | Breast Neoplasms
NCT00902954

Unknown

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer (LEANEX)

Breast Cancer
NCT00247481

Completed

ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer

Breast Cancer
NCT00632723

Completed

IRESSA™ (Gefitinib) in Breast Cancer Patients

Breast Cancer
NCT00033683

Unknown

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Breast Cancer
NCT00403988

Terminated

Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma

Breast Neoplasms
NCT00228956

Unknown

Aromatase Inhibitor Clinical Trial

Breast Cancer
NCT00093002

Completed

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Breast Cancer
NCT00001239

Completed

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms
NCT00194740

Completed

Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer

Breast Neoplasm
NCT00267449

Unknown

Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System

Breast Cancer
NCT00192062

Completed

A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer

Breast Cancer
NCT00155259

Completed

Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

Breast Cancer
NCT00107094

Completed

Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer

Breast Cancer
NCT00295100

Completed

Tamoxifen-MRI Study

Breast Cancer
NCT00419900

Unknown

Use of Hair to Diagnose the Presence of Breast Cancer

Breast Cancer
NCT00155038

Unknown

Imaging Characteristics of Breast Cancer in Women Under 40 Years of Age

Breast Cancer | Breast Neoplasms
NCT07219277

Recruiting

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

Breast Cancer, Liquid Biopsy, Early Detection
NCT07055854

Recruiting

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors (MAC)

Breast Cancer | Gynecologic Cancers
NCT07019363

Recruiting

CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

Breast Cancer | Adjuvant Therapy
NCT06833216

Not yet recruiting

Familial Breast Cancer in China

Breast Carcinoma | Genetic Variation
NCT06648278

Recruiting

Patient Care Outreach, Navigation, Technology and Support 2.0 (COUNTS2)

Cardiovascular Diseases | Breast Cancer
NCT06503783

Recruiting

A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors

Breast Cancer | Solid Tumor
NCT06495541

Not yet recruiting

The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive

Breast Cancer | Pyrotinib | RWS
NCT06416293

Recruiting

Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians (WAVES)

Breast Cancer
NCT06385990

Recruiting

Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy

Triple Negative Breast Neoplasms
NCT06154109

Not yet recruiting

Comparative Efficacy of Xiaopi Granules and Decoction in Triple-negative Breast Cancer: a Randomized Controlled Trial

Triple Negative Breast Neoplasms
NCT06097156

Recruiting

Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications

Breast Cancer | Healthy Participants
NCT05914753

Not yet recruiting

Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

Breast Cancer | Chemotherapy Effect
NCT05716958

Recruiting

Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT

Breast Cancer
NCT05623241

Recruiting

MONOCENTRIC PERSPECTIVE STUDY: USE OF LIQUID BIOPSY WITH DIAGNOSTIC IMAGING

Breast Cancer | Liquid Biopsy
NCT05240937

Not yet recruiting

The Effect of Self-compassion on Breast Cancer (cancer)

Breast Cancer | Self Compassion
NCT04860115

Not yet recruiting

Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery

Inflammatory Markers
NCT03936478

Recruiting

Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer (MAPBI)

Breast Cancer | DCIS | LCIS
NCT03213925

Recruiting

Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer

Breast Cancer | Radiation Therapy
NCT04198727

Active, not recruiting

Study of the Impact of DPD Activity on the Efficacy of Capecitabine (DPDMAX)

Breast Neoplasm Malignant Female
NCT03429907

Active, not recruiting

An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer

Malignant Neoplasm of Breast
NCT03587740

Active, not recruiting

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

Breast Cancer
NCT07447544

Active, not recruiting

Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS) (AKRA CŽS)

Breast Cancer | Central Nervous System Metastases
NCT03310957

Completed

Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

Triple Negative Breast Neoplasms

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations